Zinc in PDB 6h6r: Fragment Derived Xiap Inhibitor

Enzymatic activity of Fragment Derived Xiap Inhibitor

All present enzymatic activity of Fragment Derived Xiap Inhibitor:
2.3.2.27;

Protein crystallography data

The structure of Fragment Derived Xiap Inhibitor, PDB code: 6h6r was solved by P.A.Williams, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.56 / 2.03
Space group P 41 2 2
Cell size a, b, c (Å), α, β, γ (°) 71.352, 71.352, 105.569, 90.00, 90.00, 90.00
R / Rfree (%) 21.2 / 24.3

Other elements in 6h6r:

The structure of Fragment Derived Xiap Inhibitor also contains other interesting chemical elements:

Fluorine (F) 1 atom
Sodium (Na) 1 atom

Zinc Binding Sites:

The binding sites of Zinc atom in the Fragment Derived Xiap Inhibitor (pdb code 6h6r). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Fragment Derived Xiap Inhibitor, PDB code: 6h6r:

Zinc binding site 1 out of 1 in 6h6r

Go back to Zinc Binding Sites List in 6h6r
Zinc binding site 1 out of 1 in the Fragment Derived Xiap Inhibitor


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Fragment Derived Xiap Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn401

b:27.3
occ:1.00
NE2 A:HIS320 2.2 23.8 1.0
SG A:CYS303 2.3 26.7 1.0
SG A:CYS300 2.3 26.9 1.0
SG A:CYS327 2.4 27.0 1.0
CE1 A:HIS320 3.0 23.8 1.0
CB A:CYS300 3.0 24.1 1.0
CB A:CYS327 3.1 22.9 1.0
CB A:CYS303 3.2 23.4 1.0
CD2 A:HIS320 3.3 25.0 1.0
N A:CYS303 3.5 25.8 1.0
CA A:CYS303 3.9 25.0 1.0
ND1 A:HIS320 4.2 25.7 1.0
CG A:HIS320 4.3 23.9 1.0
CA A:CYS327 4.5 22.7 1.0
CA A:CYS300 4.5 24.0 1.0
CB A:HIS302 4.6 25.2 1.0
C A:HIS302 4.6 28.1 1.0
CB A:TYR324 4.8 24.7 1.0
C A:CYS303 4.9 28.1 1.0
N A:HIS302 4.9 26.3 1.0
CA A:HIS302 4.9 25.4 1.0
CB A:TYR329 4.9 26.7 1.0
N A:GLY304 5.0 27.2 1.0

Reference:

C.N.Johnson, J.S.Ahn, I.M.Buck, E.Chiarparin, J.E.H.Day, A.Hopkins, S.Howard, E.J.Lewis, V.Martins, A.Millemaggi, J.M.Munck, L.W.Page, T.Peakman, M.Reader, S.J.Rich, G.Saxty, T.Smyth, N.T.Thompson, G.A.Ward, P.A.Williams, N.E.Wilsher, G.Chessari. A Fragment-Derived Clinical Candidate For Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)Methyl]-5-(Hydroxymethyl)-3, 3-Dimethyl-1 H,2 H,3 H-Pyrrolo[3,2- B]Pyridin-1-Yl)-2-[(2 R,5 R)-5-Methyl-2-([(3R)-3-Methylmorpholin-4-Yl]Methyl) Piperazin-1-Yl]Ethan-1-One (ASTX660). J. Med. Chem. V. 61 7314 2018.
ISSN: ISSN 1520-4804
PubMed: 30091600
DOI: 10.1021/ACS.JMEDCHEM.8B00900
Page generated: Wed Dec 16 11:55:55 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy